Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Puma Biotechnology (PBYI)

Puma Biotechnology (PBYI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 307,889
  • Shares Outstanding, K 50,391
  • Annual Sales, $ 230,470 K
  • Annual Income, $ 30,280 K
  • EBIT $ 34 M
  • EBITDA $ 45 M
  • 60-Month Beta 1.19
  • Price/Sales 1.48
  • Price/Cash Flow 7.17
  • Price/Book 2.67

Options Overview Details

View History
  • Implied Volatility 395.08% (+303.84%)
  • Historical Volatility 34.58%
  • IV Percentile 93%
  • IV Rank 63.08%
  • IV High 587.89% on 12/03/25
  • IV Low 65.68% on 12/16/25
  • Expected Move (DTE 3) 0.04 (0.68%)
  • Put/Call Vol Ratio 0.00
  • Today's Volume 65
  • Volume Avg (30-Day) 41
  • Put/Call OI Ratio 0.04
  • Today's Open Interest 2,661
  • Open Int (30-Day) 3,216
  • Expected Range 6.24 to 6.32

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Sell
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate 0.19
  • Number of Estimates 2
  • High Estimate 0.19
  • Low Estimate 0.18
  • Prior Year 0.39
  • Growth Rate Est. (year over year) -51.28%

Price Performance

See More
Period Period Low Period High Performance
1-Month
5.48 +14.60%
on 12/17/25
6.30 -0.32%
on 01/12/26
+0.42 (+7.17%)
since 12/12/25
3-Month
4.57 +37.27%
on 11/11/25
6.30 -0.32%
on 01/12/26
+1.16 (+22.66%)
since 10/10/25
52-Week
2.58 +143.88%
on 04/09/25
6.30 -0.32%
on 01/12/26
+2.97 (+89.73%)
since 01/10/25

Most Recent Stories

More News
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, announced that on January 6, 2026, the Compensation Committee of Puma’s Board of Directors approved the grant of inducement restricted...

PBYI : 6.28 (+2.78%)
Up 91% in the Past Year, Is This Biotech Stock Red Hot or a Red Flag?

Puma Biotechnology (PBYI) relies on one product. It has weak fundamentals and has struggled to grow sales. PBYI stock has surged 91% over the past year, driven by technical momentum and speculative trading...

PBYI : 6.28 (+2.78%)
Puma Biotechnology Added to the NASDAQ Biotechnology Index (NBI)

Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, announced that it has been added to the Nasdaq Biotechnology Index (NASDAQ: NBI), effective at the close of trading on Friday, December...

PBYI : 6.28 (+2.78%)
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, announced that on December 1, 2025, the Compensation Committee of Puma’s Board of Directors approved the grant of an inducement restricted...

PBYI : 6.28 (+2.78%)
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, announced that on November 5, 2025, the Compensation Committee of Puma’s Board of Directors approved the grant of inducement restricted...

PBYI : 6.28 (+2.78%)
Puma Biotech: Q3 Earnings Snapshot

Puma Biotech: Q3 Earnings Snapshot

PBYI : 6.28 (+2.78%)
Puma Biotechnology Reports Third Quarter 2025 Financial Results

Raising 2025 NERLYNX® revenue and net income estimates

PBYI : 6.28 (+2.78%)
Puma Biotechnology to Host Conference Call to Discuss Third Quarter Financial Results

Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, will host a conference call at 1:30 p.m. PT/4:30 p.m. ET on Thursday, Nov. 6, 2025, following the release of its third quarter 2025...

PBYI : 6.28 (+2.78%)
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, announced that on October 1, 2025, the Compensation Committee of Puma’s Board of Directors approved the grant of an inducement restricted...

PBYI : 6.28 (+2.78%)
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

Puma Biotechnology, Inc. (Nasdaq: PBYI), a biopharmaceutical company, announced that on September 2, 2025, the Compensation Committee of Puma’s Board of Directors approved the grant of inducement restricted...

PBYI : 6.28 (+2.78%)

Business Summary

Puma Biotechnology, Inc. is a small cancer biotech whose only marketed product, Nerlynx (neratinib) was launched in the United Statesfor the treatment of early stage HER2-positive breast cancer in patients who have been previously treated with Roche's Herceptin-based adjuvant therapy. The drug was also...

See More

Key Turning Points

3rd Resistance Point 6.62
2nd Resistance Point 6.46
1st Resistance Point 6.37
Last Price 6.28
1st Support Level 6.12
2nd Support Level 5.96
3rd Support Level 5.87

See More

52-Week High 6.30
Last Price 6.28
Fibonacci 61.8% 4.88
Fibonacci 50% 4.44
Fibonacci 38.2% 4.00
52-Week Low 2.58

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar